| 1 |
neurofibromatosis type 2
(1142 times)
|
Neurology
(254 times)
|
VS (125 times)
NF1 (67 times)
ABI (48 times)
|
1990 Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
|
| 2 |
neurofibromin 2
(29 times)
|
Neoplasms
(15 times)
|
YAP (4 times)
CGH (2 times)
LOH (2 times)
|
2003 Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
|
| 3 |
NF type 2
(5 times)
|
Neurosurgery
(1 time)
|
NF (5 times)
NF1 (2 times)
ANs (1 time)
|
1996 The early history of the neurofibromatosis. Evolution of the concept of neurofibromatosis type 2.
|
| 4 |
neurofibromin 2 tumor suppressor gene
(4 times)
|
Molecular Biology
(2 times)
|
PAKs (1 time)
PKA (1 time)
|
2003 High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
|
| 5 |
Neurofibromatosis type 2 protein
(3 times)
|
Science
(1 time)
|
IHBDs (1 time)
JCV (1 time)
T antigen (1 time)
|
2012 Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.
|
| 6 |
NF2 gene
(3 times)
|
Neurology
(1 time)
|
GE-MRI (1 time)
MEN (1 time)
NEFH (1 time)
|
1993 Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
|
| 7 |
Neurofibromatosis 2 or bilateral acoustic neurofibromatosis
(1 time)
|
Genetics, Medical
(1 time)
|
---
|
1990 Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
|
| 8 |
neurofibromatosis 2-related
(1 time)
|
Neurology
(1 time)
|
ClinSev (1 time)
GenSev (1 time)
|
2014 Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.
|
| 9 |
Neurofibromatosis Type 2 associated
(1 time)
|
Neoplasms
(1 time)
|
BAEP (2 times)
AAO-HNS (1 time)
BAER (1 time)
|
2021 Risk Stratification for Immediate Postoperative Hearing Loss by Preoperative BAER (Brainstem Auditory Evoked Response) and Audiometry in NF2-Associated Vestibular Schwannomas.
|
| 10 |
neurofibromatosis type 2-associated meningiomas and schwannomas
(1 time)
|
Neoplasms
(1 time)
|
DLTs (1 time)
MTD (1 time)
PFS (1 time)
|
2021 A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
|
| 11 |
neurofibromin2 gene
(1 time)
|
Neoplasms
(1 time)
|
miRNAs (1 time)
MREs (1 time)
|
2019 MicroRNA‑92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
|
| 12 |
NF2 and SMARCB1 genes
(1 time)
|
Molecular Biology
(1 time)
|
NF1 (1 time)
|
2018 Clinical and molecular characterization of neurofibromatosis in southern Brazil.
|
| 13 |
NF2 cause neurofibromatosis type 2
(1 time)
|
Neoplasms
(1 time)
|
---
|
2015 Role of Merlin/NF2 inactivation in tumor biology.
|
| 14 |
NF2 mutation
(1 time)
|
Neurosurgery
(1 time)
|
NF1 (2 times)
TS (1 time)
|
2006 Hereditary neurological tumor syndromes: clues to glioma oncogenesis?
|
| 15 |
NF2+/- mice, a line heterozygous for the tumor suppressor merlin
(1 time)
|
Biological Markers
(1 time)
|
CR (1 time)
MM (1 time)
|
2018 Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2+/- mice and mouse mesothelioma cell lines from various mouse strains.
|
| 16 |
NF2/merlin underlies neurofibromatosis type 2
(1 time)
|
Neoplasms
(1 time)
|
---
|
2019 The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
|
| 17 |
None patients had signs ofneurofibromatosis type 2
(1 time)
|
Pathology
(1 time)
|
---
|
2008 [Intraneural perineurioma: clinical and morphological characteristics and a molecular genetic study of the neurofibromatosis type 2 gene].
|
A Search Service for Abbreviation / Long Form